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Abstract and Keywords  
Context: Chronic postoperative pain (CPOP) is defined as pain persisting 2 months 
after surgery that cannot be explained by other causes. Quality of recovery (QoR) 
after anaesthesia is a measure of the early postoperative health status of patients, and 
together with health-related quality of life (QoL) is considered a valid indicator of 
outcomes.  
 
Objectives: Assess the incidence and risk factors of developing CPOP after high risk 
surgeries, and evaluate its impact on the quality of life and recovery. 
 
Design: Observational, prospective study. 
 
Setting: Post-Anaesthesia Care Unit of a tertiary hospital: Centro Hospitalar São 
João, Porto, Portugal. 
 
Patients: 175 patients scheduled for elective surgery. Exclusion criteria: unable to 
give informed consent, cognitive impairment and urgent surgery. 
 
Main outcome measures: The primary end point was CPOP. CPOP was assessed 
with the Brief Pain Inventory (BPI), QoL was evaluated with the EQ-5D EuroQol five-
dimension questionnaire (EQ-5D) and QoR with the 15-item Quality of Recovery 
score (QoR-15). Evaluations were performed preoperatively (T0), 24 hours after 
surgery (T24) and 3 months after surgery (T3). 
  
Results: 49 (28%) patients had CPOP 3 months after surgery. At T3, the problems 
reported by patients with CPOP were significantly larger in all EQ-5D dimensions: 
“mobility” (p=0.001), “self-care” (p=0.001), “usual activities” (p<0.001), 
“pain/discomfort” (p<0.001), and “anxiety/depression” (p=0.002). Patients with 
CPOP had lower median EuroQol Visual analogue scale (EQ VAS) (60 vs. 87, 
p<0,001). Concerning QoR-15 scores at T24, CPOP patients had lower median scores 
for “been able to enjoy food” (p=0.022), “feeling rested” (p=0.001), “moderate pain” 
(p=0.004), “severe pain” (p=0.009), “nausea or vomiting” (p=0.049), “feeling sad or 
depressed” (p=0.013), and for global score (p<0.001). 
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Conclusions: CPOP incidence was relevant (28%) and patients with CPOP reported 
worse QoR at T24 and worse QoL at T3 than those without CPOP. 
 
Keywords: Chronic postoperative pain, quality of life, quality of recovery  
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Introduction  
Chronic postoperative pain (CPOP) is an undervalued yet prevalent 
healthcare problem associated with significant morbidity and impact on physical, 
psycho-social, cognitive, and working domains. (1) It is defined as pain persisting 2 
months after surgery that cannot be explained by other causes. (2)  A neuropathic 
pain is often present and described as ‘burning’, ‘shooting’, or ‘electric-like’, and 
together with the presence of clinical signs of hyperalgesia or allodynia. An acute 
injury or surgery leads to neuroplastic changes in the peripheral and central nervous 
system in response to the nociceptive input. These changes cause nervous system 
hypersensitivity, and, if persistent, often can lead to debilitating chronic pain.  
Three linked processes are implicated in the transition from acute to chronic 
pain and may serve as targets for prevention: i) peripheral sensitization, ii) central 
sensitization, and iii) descending modulation. (3) CPOP can occur with any type of 
surgery, but is more common following procedures with significant nerve or tissue 
damage. Prevalence varies greatly; the estimated prevalence for surgeries with higher 
risk of developing CPOP is: mastectomy 20–50%, amputation 50–85%, hysterectomy 
5–30%, hernia repair 5–35%, and thoracotomy 5–65% (2). Risk factors include the 
type of surgery, preoperative pain, moderate-to-severe acute post-operative pain, 
neurotoxic radio or chemotherapy and psycho-social factors, among others (Fig. 1). 
(1)  
Health-related Quality of Life (QoL) questions about function and perceived 
physical and mental health are generally considered valid indicators of service needs 
and intervention outcomes. (4) Recovery after surgery and anaesthesia is a complex 
process dependent on patient, surgical, and anaesthetic characteristics, as well as the 
presence of any of numerous adverse sequelae. However, it has been considered a 
relevant measure of the early postoperative health status of patients. Evaluating QoL 
and QoR may be essential for better outcomes studies in both surgery and 
anaesthesia. (5)  
The aim of our study was to assess the incidence and risk factors of 
developing  CPOP after high risk surgeries (mastectomy, amputation, hysterectomy, 
cholecystectomy, hernia repair, thoracotomy, thyroidectomy, and knee/hip 
arthroplasty), and to evaluate its impact on quality of life and recovery. 
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Methods 
The Institutional Review Board of the Centro Hospitalar São João approved 
the study protocol (Centro Hospitalar São João Ethics Committee, Alameda Hernâni 
Monteiro, 4200-310 Porto, Portugal - Chairperson Prof Filipe Nuno Alves Santos 
Almeida, Ethical approval number 198-13), and written informed consent was 
obtained from all patients. This prospective cohort study was carried out in the 
multidisciplinary Post-Anaesthesia Care Unit (PACU) at the 1124-bed Centro 
Hospitalar São João, a community teaching hospital in Porto, Portugal. It was 
conducted in patients scheduled for elective surgery admitted in the PACU from June 
to August 2013.  
Inclusion criteria were all consecutive adult patients undergoing orthopedic 
(limb amputation, total knee and hip arthroplasty), thoracic (thoracotomy), 
gynecologic (hysterectomy), and general surgery (mastectomy, thyroidectomy, 
inguinal hernia repair and cholecystectomy). Patients unable to give informed 
consent, patients with cognitive impairment (Mini-mental State Examination < 24) 
and patients submitted to emergent or urgent surgery were excluded. 
The following clinical variables were recorded preoperatively (T0): age, sex, 
body weight, height, body mass index (BMI) and the American Society of 
Anaesthesiologists physical status (ASA-PS). Additionally, pre-admission 
comorbidities and history of hypertension, diabetes, hyperlipidaemia, chronic 
obstructive pulmonary disease (COPD), cerebrovascular disease, psychiatric disease, 
smoking and benzodiazepines therapy were recorded. Preoperative cognitive function 
was evaluated with the Mini Mental State Examination. 
Intra-operatively, we recorded duration and type of anaesthesia. Analgesic or 
anxiolytic drugs administered in the 24-hour period after surgery were registered. 
Brief Pain Inventory (Appendix 1) was used to assess CPOP. BPI is a widely 
used questionnaire designed to assess the patient-reported outcome of pain making it 
a suitable method for detecting chronic pain in those adults who are able to provide 
information about them. (6, 7) 
QoL was evaluated with the EQ-5D EuroQol five-dimension 
questionnaire (Appendix 2) and QoR after anaesthesia with the 15-item Quality of 
Recovery score (Appendix file 3). EQ-5D is a generic questionnaire that measures 
health outcome and was developed at the European level. The Portuguese version of 
EQ-5D was designed in 1998. (8) The EQ-5D comprises two parts: the EQ-5D self-
classifier, a self-reported description of health problems according to a five 
dimensional classification i.e., mobility, self-care, usual activities, pain/discomfort 
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and anxiety/depression; the EQ VAS, a self-rated health status using a visual 
analogue scale (VAS), similar to a thermometer, to record perceptions of participants 
own current overall health; the scale is graduated from 0 (the worst imaginable 
health state) to 100 (the best imaginable state). An index (EQ Index), based on the 
five dimensions and the EQ VAS and ranging from 0 to 100, was also calculated and 
used to describe the overall QoL of the patients. (9, 10) We categorized patients into 
two groups considering their answers to EQ-5D: those with no referred problems and 
those with problems, regardless of their severity. QoR-15 is a short-form version of 
the 40-question original questionnaire and provides a valid, reliable, responsive, 
easy-to-use, extensive, and efficient method of evaluating the quality of postoperative 
recovery. It may be used to assess the impact of changes in health care delivery for 
quality assurance purposes. (5) We performed QoR-15 before surgery (T0) and 24 
hours after surgery (T24). 
Quality of life and BPI evaluations were performed preoperatively (T0) and 3 
months after surgery (T3) in 175 patients. The primary endpoint was CPOP. Each 
patient admitted was evaluated prospectively for the diagnosis of CPOP using BPI 
conducted by research staff physicians. All patients yielding a positive BPI at 3 
months post-operatively were considered to have CPOP. 
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Results  
Admission and pre-admission patient characteristics (T0) 
 175 patients were enrolled in this study (Table 2), 62 (35%) were male and 113 
(65%) were female. The median age was 62 years old and 140 (80%) patients were 
considered ASA-PS I/II and 35 (20%) ASA-PS III/IV. The median BMI was 26 kg/m2. 
84 (48%) patients had history of hypertension, 61 (31%) of dyslipidaemia, 11 (6%) of 
COPD, 34 (19%) of diabetes, 10 (6%) of cerebrovascular disease, and 24 (14%) of 
psychiatric disease. 24 (14%) patients were smokers. 42 (24%) patients confirmed 
taking benzodiazepines daily as usual medication. 
 Concerning type of surgery, 26 (15%) patients underwent thyroidectomy, 14 
(8%) thoracotomy, 13 (7%) amputation, 25 (15%) cholecystectomy, 29 (17%) inguinal 
hernia repair, 12 (7%) hysterectomy, 37 (21%) mastectomy, and 19 (11%) orthopaedic 
surgery. Type of surgery was not associated with CPOP at 3 months (p=0.090) (Table 
3). 
 35 (20%) patients reported pain before surgery. Patients with CPOP at T3, 
had more frequently “pain before surgery” (p<0.001) and were less frequently on 
“benzodiazepines therapy” (p=0.015). 
 At T0, the problems reported by patients with CPOP were significantly larger 
in all EQ-5D dimensions: “mobility” (p=0.024), “self-care” (p=0.001), “usual 
activities” (p<0.001), and “pain/discomfort” (p<0.001), but “anxiety/depression” 
(p=0.797). Patients with CPOP reported lower median EuroQol Visual analogue scale 
(EQ VAS) (65 vs. 80, p<0,001), and lower VAS index (64 vs. 91, p<0,001) (Table 4).  
 Concerning QoR-15 scores, CPOP patients presented with lower total median 
scores at T0 in the following domains: “getting support from hospital doctors and 
nurses” (10 vs. 10, p=0.016), “able to return to work or usual home activities” (10 vs. 
10, p=0.026), “moderate pain” (9 vs. 10, p<0.001), “severe pain” (10 vs. 10, p<0.001) 
and for a “global score” (125 vs. 132, p=0.021) (Table 5). 
During surgery and PACU stay results 
Regarding anaesthesia, 146 (83%) patients received general or combined 
general-locorregional anaesthesia while 29 (17%) received locorregional anaesthesia. 
The median duration of the anaesthesia was 120 minutes and median PACU stay was 
90 minutes. The median value for pain at PACU admission and discharge using VAS 
was 0 (Table 6). 
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24h post-operatively (T24) results 
 At T24, 81 (46%) patients reported pain. Pain 24 hours after surgery was 
associated with more CPOP at 3 months follow-up (p=0.021). QoR-15 mean global 
score was lower for CPOP patients (103 vs. 121, p<0.001). At T24, when evaluating 
each domain of QoR-15, CPOP patients have lower scores at “been able to enjoy food” 
(5 vs. 9, p=0.022), “feeling rested” (7 vs. 9, p=0.001), “moderate pain” (5 vs. 7, 
p=0.004), “severe pain” (10 vs. 10, p=0.009), “nausea or vomiting” (10 vs. 10, 
p=0.049), and “feeling sad or depressed”(8 vs. 10, p=0.013) (Table 5). 
3 months post-operatively (T3) results 
49 (28%) patients had CPOP 3 months after surgery. Patients with CPOP at 3 
months follow-up had more frequently pain 24 hours after surgery (p=0.021). 
Moreover, half of our patients with positive BPI before surgery still had pain at T3. 
At this time, the problems reported by patients with CPOP were significantly 
larger in all EQ-5D dimensions: “mobility” (p=0.001), “self-care” (p=0.001), “usual 
activities” (p<0.001), “pain/discomfort” (p<0.001), and “anxiety/depression” 
(p=0.002). Patients with CPOP reported lower median EuroQol Visual analogue scale 
(EQ VAS) (60 vs. 87, p<0,001) as well as lower VAS index (64 vs. 91, p<0,001) (Table 
4).  
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Discussion  
Our study reports that 3 months after surgery 28% of patients had CPOP. This 
incidence, similar to those of the previous studies, may be viewed as an important 
indicator regarding the economic burden and the significant impact on quality of life. 
In our study, a considerable number of patients, all well characterized 
according to their medical history, were submitted to various types of surgeries, 
different kinds of anaesthetic management and diverse times of recovery. The 
population was extensively evaluated by several parameters that are known to 
influence the quality of recovery and it was possible to determine its impact on 
quality of life. According to our knowledge, this is also the first study recording the 
incidence of chronic postoperative pain after thyroidectomy.  
Regarding risk factors and predictors of CPOP, previous studies reported that 
age (11) and gender (12, 13) are non-modifiable patient-related risk factors: younger 
patients and female patients tend to have a higher risk of developing CPOP than older 
patients and male patients. However, in our study we did not find any difference 
according to age or gender. Regarding modifiable risk factors, previous studies found 
that high body mass index (≥25) (11), severe preoperative pain (13-15), higher 
incidence of postoperative complications (16), and the presence of chronic pain in 
other areas of the body (17) were also considered to be risk factors. Although in the 
present study, we could not find that a higher BMI and the presence of chronic pain 
in other areas of the body were associated with an increase in CPOP incidence, we 
could find that CPOP was related with severe postoperative pain as reported in many 
previous studies (2, 3), which corroborates the thesis that CPOP may be associated 
with severe and/or poorly controlled acute pain after surgery. Thus, we may theorize 
that aggressive acute pain management may diminish the development of CPOP. (2, 
3) Moreover, certain psychological factors including anxiety, depression, 
posttraumatic stress disorder, past life traumas (18), catastrophizing (19), and stress 
and duration of disability (time to return from work) (20) were associated with CPOP 
in various studies. We did not perform a psychological evaluation of our patients by a 
specialized therapist; nonetheless we enquired patients about the presence of any 
psychiatric disorder and psychiatric medication use. We observed that those taking 
benzodiazepines daily had less frequently CPOP at 3 months after surgery, which is in 
accordance to previous studies (21) regarding psychological status of patients. In a 
particularly anxious patient, pre-existing pain may be intensified by fear and anxiety, 
and benzodiazepines may reduce the amount of intraoperative anaesthetic and 
postoperative analgesic needs. (21) During the intraoperative and postoperative 
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periods, important surgical factors include: the type of surgery (22), anatomical 
location of surgery, surgical technique (23), and the extent of nerve injury and tissue 
ischemia (23). (3) Some surgeries are associated with higher incidence of CPOP, such 
as mastectomy, thoracotomy and inguinal hernia repair.  
In addition, we did not find differences in CPOP incidence between the 
different types of surgeries, but we must recognise that the limited number of 
patients and the relatively high number of surgeries’ groups may have limited any 
conclusion.  
Type of anaesthesia has been implicated on the development of CPOP but in 
the present study we did not find any difference according to this variable, which is 
consistent with previous results. (24)  
Although several risk factors have been implicated in the development of this 
pain condition, no single factor appears to dominate. It is believed that less than 20% 
of the overall risk can be predicted by the severity of postoperative pain. (25) Yet, it 
might be possible that the cumulative risk is crucial in patients with multiple risk 
factors. Whenever possible, identifying and aggressively treating the underlying 
cause of nervous tissue injury is essential. This may explain why half of our patients 
with positive BPI before surgery still had pain at T3. Surgery on a painful body area 
did not treat the pain, which should point us towards an alternate cause. 
 Patients who presented CPOP after surgery included those with pre-existing 
pain (positive BPI before surgery) and those with newly developed pain. Before 
surgery, patients who later reported CPOP presented significantly more problems in 
all EQ-5D dimensions except “anxiety/depression”. At T3, patients with CPOP 
reported significantly more problems in all EQ-5D dimensions. Before and after 
surgery, these patients also reported lower mean EQ VAS. All mentioned results show 
a clear relationship between CPOP and poor own perception of health related-QoL. 
When evaluating each domain of QoR-15 at T24, CPOP patients had lower 
scores at “been able to enjoy food”, “feeling rested”, “moderate pain”, “severe pain”, 
“nausea or vomiting”, and “feeling sad or depressed”. 
  We propose that some of the baseline values obtained preoperatively may be 
underestimated providing many patients were possibly anxious, medically unstable 
or in pain before surgery. However, we should not ignore that CPOP patients already 
felt more pain, moderate and severe, before surgery when compared with those 
without CPOP at T3. This may also explain why some patients develop pain and 
others do not, leading us to believe certain patients have a higher risk for developing 
CPOP. It is essential to have means to discriminate between these two groups in 
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order to find strategies to prevent CPOP. Although we believe prevention is the key, 
its effect is often small and the evidence is not consistent. Currently, there is almost 
nothing suggesting a reliable and effective method for prevention is possible. 
Nonetheless, as previous mentioned, the severity of postoperative pain has been 
recognized as a predicting factor for chronic pain in many studies. We have excellent 
techniques aimed at this and it may be that focusing more attention on patients in 
severe pain after surgery will be of benefit. (2) Future studies concentrating on the 
effect of aggressive management of acute postoperative pain on long-term CPOP are 
crucial. 
 Additionally, previous studies reported that QoR-15 was able to discriminate 
between men and women (26, 27) and it has already been found a negative 
association between QoR-15 and duration of surgery and duration of time spent in 
PACU. However, in our study, no relation has been found between QoR-15 score and 
patient age (28, 29), possibly explained by the fact that older people tend to report 
less pain, nausea and vomiting and scoring their recovery more positively. (5) Despite 
this, our study shows a clear relation between a worse recovery and the development 
of CPOP. Not only did CPOP patients felt more pain, moderate or severe, before and 
after surgery compared to those who were CPOP-negative at T3, but they also 
experienced incapacity to appreciate food and to feel rested, nausea and vomiting, 
and felt sad or depressed, immediately after surgery. All these in addition to an 
overall worse QoR-rate both at T0 and T24 suggest these patients have poorer quality 
of recovery and consequently lower quality of life. 
This study has several limitations that must be addressed. We did not exclude 
patients with pain before surgery and that may be a confounding factor. The sample 
was not homogenous since we included adult patients with a variety of surgeries. In 
this study the anaesthetic management was not standardized: there was no 
anaesthetic protocol to follow and the postoperative management was not guided by 
any protocol. We also had a small patient population and we studied patients 
submitted to wide variety of surgeries and this may have increased statistical type II 
error. Even so, the sample may have been very small to detect other statistically 
significant factors. Moreover, we did not study some variables known to be associated 
with CPOP like the nature, intensity, and duration of pre-surgical pain. 
In conclusion, CPOP is an increasingly prevalent healthcare problem 
associated with significant morbidity and it represents an important outcome 
measure after surgery. In our study its incidence was relevant (28%) and patients 
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with CPOP reported worse QoR at T24 using QoR-15, and worse QoL 3 months after 
surgery with EQ-5D than those without CPOP.  
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Tables and Figures 
Figure 1 - Risk factors for the development of CPOP. 
As illustrated by McGreevy et al. (3) 
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Table 1 – Prevalence of CPOP according to type of surgery (2, 3, 30, 31). 
 
 
 Prevalence of CPOP 
Mastectomy 20–50% 
Amputation 30–85% 
Hysterectomy 5–32% 
Hernia repair 5–35% 
Thoracotomy 5–65% 
Thyroidectomy unknown 
Total knee arthroplasty 19-30% 
Total hip arthroplasty 28-41% 
Cholecystectomy 26% 
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Table 2 – Pre-admission patient characteristics. 
 
 
 All 
patients 
(n=175) 
No CPOP at T3 
(n=126/72%) 
CPOP at T3 
(n=49/28%) 
p 
Age (years), median 62 (48-70) 61 (46-69) 63 (53-72) 0.207 
Gender, n (%) 
 Male 
 Female 
 
62 (35) 
113 (65) 
 
49 (39) 
77 (61) 
 
13 (27) 
36 (74) 
0.125 
ASA, n (%) 
 I/II 
 III/IV 
 
140 (80) 
35 (20) 
 
99 (79) 
27 (21) 
 
41 (84) 
8 (16) 
0.449 
BMI (kg/m2), median 26 (23-30) 26 (23-30) 26 (23-28) 0.543 
Hypertension, n (%) 84 (48) 62 (49) 22 (45) 0.608 
Dyslipidaemia, n (%) 61 (31) 46 (37) 15 (31) 0.462 
Cerebrovascular 
disease, n (%) 
10 (6) 7 (6) 3 (6) 0.567 
Diabetes, n (%) 34 (19) 27 (21) 7 (14) 0.284 
COPD, n (%) 11 (6) 7 (6) 4 (8) 0.370 
Smoking, n (%) 24 (14) 17 (14) 7 (14) 0.891 
Psychiatric disease, n 
(%) 
24 (14) 14 (11) 10 (20) 0.108 
Benzodiazepines 
therapy, n (%) 
42 (24) 24 (19) 18 (37) 0.015 
Pain before 
surgery, n (%) 
35 (20) 17 (14) 18 (37) <0.001 
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Table 3 – CPOP incidence according to the type of surgery. 
 
 
 All 
patients 
(n=175) 
No CPOP at 
T3 
(n=126/72%) 
CPOP at T3 
(n=49/28%) 
p 
Type of surgery, n (%)    0.090 
 Thyroidectomy 
 Thoracotomy 
 Amputation 
 Cholecystectomy 
 Hernia repair 
 Hysterectomy 
 Mastectomy 
 Hip/Knee 
arthroplasty 
26 (15) 
14 (8) 
13 (7) 
25 (14) 
29 (17) 
12 (7) 
37 (21) 
19 (11) 
20 (16) 
11 (9) 
9 (7) 
23 (18) 
21 (17) 
9 (7) 
24 (19) 
9 (7) 
6 (12) 
3 (6) 
4 (8) 
2 (4) 
8 (16) 
3 (6) 
13 (27) 
10 (20) 
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Table 4 – EQ-5D results. 
 
 
 All 
patients 
(n=175) 
No CPOP at T3 
(n=126/72%) 
CPOP at T3 
(n=49/28%) 
P 
Before surgery (T0), n (%) 
Mobility 119 (68) 91 (74) 28 (58) 0.024 
Self-care 142 (81) 108 (88) 34 (71) 0.001 
Usual activities 126 (72) 97 (79) 29 (60) <0.001 
Pain/Discomfort 105 (60) 85 (69) 20 (42) <0.001 
Anxiety/Depression 55 (31) 42 (34) 13 (27) 0.797 
VAS 75 (50-
85) 
80 (50-90) 65 (46-80) 0.039 
VAS index 91 (64-
100) 
91 (81-100) 64 (50-81) <0.001 
     
After surgery (T3), n (%) 
Mobility 123 (70) 99 (79) 24 (49) 0.001 
Self-care 131 (75) 105 (83) 26 (53) 0.001 
Usual activities 115 (66) 100 (79) 15 (31) <0.001 
Pain/Discomfort 108 (62) 101 (80) 7 (14) <0.001 
Anxiety/Depression 98 (56) 80 (64) 18 (37) 0.002 
VAS 80 (60-
90) 
87 (70-95) 60 (50-80) <0.001 
VAS index 91 (64-
100) 
91 (81-100) 64 (50-81) <0.001 
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Table 5 – QoR-15 results 
 All patients 
(n=175) 
No CPOP at T3 
(n=126) 
CPOP at T3 
(n=49) 
P 
Before surgery (T0) 
1. Able to breathe easy 10 (10-10) 10 (10-10) 10 (10-10) 0.876 
2. Been able to enjoy food 10 (10-10) 10 (10-10) 10 (8-10) 0.072 
3. Feeling rested 9 (5-10) 8 (5-10) 9 (5-10) 0.684 
4. Have had a good sleep 9 (5-10) 9 (5-10) 7 (4-10) 0.401 
5. Able to look after personal toilet and 
hygiene unaided 
10 (10-10) 10 (10-10) 10 (10-10) 0.239 
6. Able to communicate with family or 
friends 
10 (10-10) 10 (10-10) 10 (10-10) 0.687 
7. Getting support from hospital 
doctors and nurses 
10 (10-10) 10 (10-10) 10 (10-10) 0.016 
8. Able to return to work or usual 
home activities 
10 (8-10) 10 (9-10) 10 (6-10) 0.026 
9. Feeling comfortable and in control 10 (7-10) 10 (8-10) 10 (5-10) 0.097 
10. Having a feeling of general well-
being 
9 (6-10) 9 (7-10) 8 (5-10) 0.105 
11. Moderate pain 10 (8-10) 10 (10-10) 9 (4-10) <0.001 
12. Severe pain 10 (10-10) 10 (10-10) 10 (8-10) <0.001 
13. Nausea or vomiting 10 (10-10) 10 (10-10) 10 (10-10) 0.177 
14. Feeling worried or anxious 5 (3-9) 5 (2-9) 5 (3-9) 0.997 
15. Feeling sad or depressed 8 (5-10) 9 (5-10) 7 (4-10) 0.107 
Total 131 (114-140) 132 (119-142) 125 (99-138) 0.021 
24h after surgery (T24) 
1. Able to breathe easy 10 (8-10) 10 (9-10) 10 (7-10) 0.094 
2. Been able to enjoy food 8 (4-10) 9 (5-10) 5 (1-10) 0.022 
3. Feeling rested 8 (6-10) 9 (7-10) 7 (5-8) 0.001 
4. Have had a good sleep 7 (4-9) 8 (5-10) 7 (2-9) 0.366 
5. Able to look after personal toilet and 
hygiene unaided 
8 (2-10) 9 (2-10) 7 (2-10) 0.265 
6. Able to communicate with family or 
friends 
10 (9-10) 10 (9-10) 10 (7-10) 0.144 
7. Getting support from hospital 
doctors and nurses 
10 (9-10) 10 (9-10) 10 (9-10) 0.973 
8. Able to return to work or usual 
home activities 
6 (2-9) 7 (3-9) 5 (1-9) 0.246 
9. Feeling comfortable and in control 9 (6-10) 9 (7-10) 8 (5-10) 0.165 
10. Having a feeling of general well-
being 
8 (5-10) 8 (6-10) 7 (5-9) 0.096 
11. Moderate pain 5 (3-10) 7 (4-10) 5 (3-6) 0.004 
12. Severe pain 10 (9-10) 10 (10-10) 10 (7-10) 0.009 
13. Nausea or vomiting 10 (8-10) 10 (10-10) 10 (6-10) 0.049 
14. Feeling worried or anxious 8 (5-10) 8 (5-10) 8 (3-10) 0.506 
15. Feeling sad or depressed 10 (6-10) 10 (8-10) 8 (5-10) 0.013 
Total 115 (98-128) 121 (104-133) 103 (83-118) <0.001 
  
23 
 
Table 6 – During surgery and at PACU stay results. 
 
 
 All patients 
(n=175) 
No CPOP at 
T3 (n=126) 
CPOP at 
T3 (n=49) 
P 
Anaesthesia duration (min), median 120 120 120 0.107 
Type of anaesthesia, n (%) 
 General/Combined general-
locorregional 
 Locorregional 
 
146 (83) 
 
29 (17) 
 
109 (86) 
 
17 (14) 
 
37 (75) 
 
12 (25) 
0.149 
PACU stay duration (min), median 90 (70-120) 90 (66-115) 95 (75-128) 0.470 
VAS for pain at PACU admission 0 (0-5) 0 (0-5) 1 (0-5) 0.411 
VAS for pain at PACU discharge 0 (0-2) 0 (0-2) 0 (0-2) 0.897 
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Appendix 1 – Brief Pain Inventory (BPI) 
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Appendix 2 – EQ-5D: EuroQol five-dimension questionnaire 
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Appendix 3 – QoR-15: 15-item Quality of Recovery score 
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